Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cerebral vasoconstrictor mediators

N Toda1, T Okamura

  • 1Department of Pharmacology, Shiga University of Medical Sciences, Ohtsu, Japan.

Pharmacology & Therapeutics
|February 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Use of vertebral left atrial size for staging of dogs with myxomatous valve disease.

Journal of veterinary cardiology : the official journal of the European Society of Veterinary Cardiology·2020
Same author

Measurement and comparison of individual external doses of high-school students living in Japan, France, Poland and Belarus-the 'D-shuttle' project.

Journal of radiological protection : official journal of the Society for Radiological Protection·2015
Same author

Relationship between glomerular filtration rate and plasma N-terminal pro B-type natriuretic peptide concentrations in dogs with chronic kidney disease.

Veterinary journal (London, England : 1997)·2013
Same author

A multicentre randomised phase II trial of gemcitabine alone vs gemcitabine and S-1 combination therapy in advanced pancreatic cancer: GEMSAP study.

British journal of cancer·2012
Same author

Large voltage-induced magnetic anisotropy change in a few atomic layers of iron.

Nature nanotechnology·2009
Same author

Endoscopic transpapillary approach to the gallbladder for diagnosing gallbladder cancer.

Canadian journal of gastroenterology = Journal canadien de gastroenterologie·2007
Same journal

Protein acetylation modification in tissue fibrosis: Opportunities and challenges.

Pharmacology & therapeutics·2026
Same journal

Nipocalimab and other FcRn blockers in neuromuscular disorders.

Pharmacology & therapeutics·2026
Same journal

C26:0-lysophosphatidylcholine in X-linked adrenoleukodystrophy.

Pharmacology & therapeutics·2026
Same journal

The CircRNA/miRNA axis in breast cancer: From molecular mechanisms to clinical translation.

Pharmacology & therapeutics·2026
Same journal

Glymphatic-meningeal lymphatic dysfunction in epilepsy: novel mechanistic insights and therapeutic avenues.

Pharmacology & therapeutics·2026
Same journal

The neurovascular unit under siege: Molecular mechanisms and potential drug target for cerebral edema.

Pharmacology & therapeutics·2026
See all related articles

This review examines how vasoconstrictors affect brain blood flow and their role in cerebral circulatory disorders. Understanding these mediators

Area of Science:

  • Neuroscience
  • Pharmacology
  • Physiology

Background:

  • Endogenous vasoconstrictor mediators are crucial for regulating cerebral vascular resistance and blood flow.
  • These mediators play a significant role in the pathogenesis of cerebral circulatory disturbances.
  • Vasoconstrictors are therapeutically relevant for conditions involving cerebral vasodilation.

Purpose of the Study:

  • To review the characteristics of vasoconstrictor action on isolated mammalian cerebral arteries.
  • To compare the responses of cerebral arteries from primate and subprimate mammals, including humans.
  • To evaluate the physiological roles, pathogenetic involvement, and therapeutic potential of vasoconstrictors.

Main Methods:

  • Review of existing literature on vasoconstrictor actions.

Related Experiment Videos

  • Analysis of studies involving isolated cerebral arteries from various mammalian species.
  • Comparative analysis of responses across different species, including primates and humans.

    • Main Results:

    • Variations exist in the response of cerebral arteries to vasoconstrictors between primate and subprimate mammals.
    • Detailed characteristics of the action of various vasoconstrictors (amines, peptides, prostanoids) were described.
    • Information on similarities and differences in mediator responses is vital for clinical and physiological understanding.

    Conclusions:

    • Understanding species-specific responses of cerebral arteries to vasoconstrictors is essential.
    • This knowledge aids in evaluating the physiological significance and therapeutic utility of vasoconstrictors in humans.
    • Further research into these mediators can inform treatments for cerebral circulatory disorders.